Archives of Pharmacal Research

, Volume 36, Issue 2, pp 167–177 | Cite as

Genetics of type 2 diabetes and potential clinical implications



Type 2 diabetes (T2DM) is a common complex metabolic disorder that has a strong genetic component. Recent advances in genome-wide association studies have revolutionized our knowledge regarding the genetics of T2DM. There are at least 64 common genetic variants that are strongly associated with T2DM. However, the pathophysiologic roles of these variants are mostly unknown and require further functional characterization. The variants identified so far have a small effect size and their added effect explains less than 10 % of the T2DM heritability. The current ongoing whole exome and whole genome studies of T2DM are focused on identifying functionally important rare variants that have a stronger effect. Through these efforts, we will have a better understanding of the genetic architecture of T2DM and its pathophysiology. The potential clinical applications of genetic studies of T2DM include risk prediction, identification of novel therapeutic targets, genetic prediction of efficacy and toxicity of anti-diabetic medications, and eventually optimization of patient care through personalized genomic medicine. We hope further research in genetics of T2DM could aid patient care and improve outcomes of T2DM patients.


Genetics Genomic medicine Risk prediction Type 2 diabetes 


  1. Altshuler, D., J.N. Hirschhorn, M. Klannemark, C.M. Lindgren, M.C. Vohl, J. Nemesh, C.R. Lane, S.F. Schaffner, S. Bolk, C. Brewer, T. Tuomi, D. Gaudet, T.J. Hudson, M. Daly, L. Groop, and E.S. Lander. 2000. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nature Genetics 26: 76–80.PubMedCrossRefGoogle Scholar
  2. American Diabetes Association. 2012. Diagnosis and classification of diabetes mellitus. Diabetes Care 35(Suppl 1): S64–S71.CrossRefGoogle Scholar
  3. Ashley, E.A., A.J. Butte, M.T. Wheeler, R. Chen, T.E. Klein, F.E. Dewey, J.T. Dudley, K.E. Ormond, A. Pavlovic, A.A. Morgan, D. Pushkarev, N.F. Neff, L. Hudgins, L. Gong, L.M. Hodges, D.S. Berlin, C.F. Thorn, K. Sangkuhl, J.M. Hebert, M. Woon, H. Sagreiya, R. Whaley, J.W. Knowles, M.F. Chou, J.V. Thakuria, A.M. Rosenbaum, A.W. Zaranek, G.M. Church, H.T. Greely, S.R. Quake, and R.B. Altman. 2010. Clinical assessment incorporating a personal genome. Lancet 375: 1525–1535.PubMedCrossRefGoogle Scholar
  4. Becker, M.L., L.E. Visser, R.H. Van Schaik, A. Hofman, A.G. Uitterlinden, and B.H. Stricker. 2009. Genetic variation in the multidrug and toxin extrusion 1 transporter protein influences the glucose-lowering effect of metformin in patients with diabetes: a preliminary study. Diabetes 58: 745–749.PubMedCrossRefGoogle Scholar
  5. Bonnefond, A., N. Clement, K. Fawcett, L. Yengo, E. Vaillant, J.L. Guillaume, A. Dechaume, F. Payne, R. Roussel, S. Czernichow, S. Hercberg, S. Hadjadj, B. Balkau, M. Marre, O. Lantieri, C. Langenberg, N. Bouatia-Naji, G. Charpentier, M. Vaxillaire, G. Rocheleau, N.J. Wareham, R. Sladek, M.I. Mccarthy, C. Dina, I. Barroso, R. Jockers, and P. Froguel. 2012. Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes. Nature Genetics 44: 297–301.PubMedCrossRefGoogle Scholar
  6. Bouatia-Naji, N., A. Bonnefond, C. Cavalcanti-Proenca, T. Sparso, J. Holmkvist, M. Marchand, J. Delplanque, S. Lobbens, G. Rocheleau, E. Durand, F. De Graeve, J.C. Chevre, K. Borch-Johnsen, A.L. Hartikainen, A. Ruokonen, J. Tichet, M. Marre, J. Weill, B. Heude, M. Tauber, K. Lemaire, F. Schuit, P. Elliott, T. Jorgensen, G. Charpentier, S. Hadjadj, S. Cauchi, M. Vaxillaire, R. Sladek, S. Visvikis-Siest, B. Balkau, C. Levy-Marchal, F. Pattou, D. Meyre, A.I. Blakemore, M.R. Jarvelin, A.J. Walley, T. Hansen, C. Dina, O. Pedersen, and P. Froguel. 2009. A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk. Nature Genetics 41: 89–94.PubMedCrossRefGoogle Scholar
  7. Chen, R., G.I. Mias, J. Li-Pook-Than, L. Jiang, H.Y. Lam, E. Miriami, K.J. Karczewski, M. Hariharan, F.E. Dewey, Y. Cheng, M.J. Clark, H. Im, L. Habegger, S. Balasubramanian, M. O’huallachain, J.T. Dudley, S. Hillenmeyer, R. Haraksingh, D. Sharon, G. Euskirchen, P. Lacroute, K. Bettinger, A.P. Boyle, M. Kasowski, F. Grubert, S. Seki, M. Garcia, M. Whirl-Carrillo, M. Gallardo, M.A. Blasco, P.L. Greenberg, P. Snyder, T.E. Klein, R.B. Altman, A.J. Butte, E.A. Ashley, M. Gerstein, K.C. Nadeau, H. Tang, and M. Snyder. 2012. Personal omics profiling reveals dynamic molecular and medical phenotypes. Cell 148: 1293–1307.PubMedCrossRefGoogle Scholar
  8. Cho, Y.S., C.H. Chen, C. Hu, J. Long, R.T. Ong, X. Sim, F. Takeuchi, Y. Wu, M.J. Go, T. Yamauchi, Y.C. Chang, S.H. Kwak, R.C. Ma, K. Yamamoto, L.S. Adair, T. Aung, Q. Cai, L.C. Chang, Y.T. Chen, Y. Gao, F.B. Hu, H.L. Kim, S. Kim, Y.J. Kim, J.J. Lee, N.R. Lee, Y. Li, J.J. Liu, W. Lu, J. Nakamura, E. Nakashima, D.P. Ng, W.T. Tay, F.J. Tsai, T.Y. Wong, M. Yokota, W. Zheng, R. Zhang, C. Wang, W.Y. So, K. Ohnaka, H. Ikegami, K. Hara, Y.M. Cho, N.H. Cho, T.J. Chang, Y. Bao, A.K. Hedman, A.P. Morris, M.I. Mccarthy, R. Takayanagi, K.S. Park, W. Jia, L.M. Chuang, J.C. Chan, S. Maeda, T. Kadowaki, J.Y. Lee, J.Y. Wu, Y.Y. Teo, E.S. Tai, X.O. Shu, K.L. Mohlke, N. Kato, B.G. Han, and M. Seielstad. 2012a. Meta-analysis of genome-wide association studies identifies eight new loci for type 2 diabetes in east Asians. Nature Genetics 44: 67–72.CrossRefGoogle Scholar
  9. Cho, Y.S., J.Y. Lee, K.S. Park, and C.W. Nho. 2012b. Genetics of type 2 diabetes in east asian populations. Current diabetes reports 12(6): 686–696.PubMedCrossRefGoogle Scholar
  10. De Miguel-Yanes, J.M., P. Shrader, M.J. Pencina, C.S. Fox, A.K. Manning, R.W. Grant, J. Dupuis, J.C. Florez, R.B. D’agostino Sr, L.A. Cupples, and J.B. Meigs. 2011. Genetic risk reclassification for type 2 diabetes by age below or above 50 years using 40 type 2 diabetes risk single nucleotide polymorphisms. Diabetes Care 34: 121–125.PubMedCrossRefGoogle Scholar
  11. Dupuis, J., C. Langenberg, I. Prokopenko, R. Saxena, N. Soranzo, A.U. Jackson, E. Wheeler, N.L. Glazer, N. Bouatia-Naji, A.L. Gloyn, C.M. Lindgren, R. Magi, A.P. Morris, J. Randall, T. Johnson, P. Elliott, D. Rybin, G. Thorleifsson, V. Steinthorsdottir, P. Henneman, H. Grallert, A. Dehghan, J.J. Hottenga, C.S. Franklin, P. Navarro, K. Song, A. Goel, J.R. Perry, J.M. Egan, T. Lajunen, N. Grarup, T. Sparso, A. Doney, B.F. Voight, H.M. Stringham, M. Li, S. Kanoni, P. Shrader, C. Cavalcanti-Proenca, M. Kumari, L. Qi, N.J. Timpson, C. Gieger, C. Zabena, G. Rocheleau, E. Ingelsson, P. An, J. O’connell, J. Luan, A. Elliott, S.A. Mccarroll, F. Payne, R.M. Roccasecca, F. Pattou, P. Sethupathy, K. Ardlie, Y. Ariyurek, B. Balkau, P. Barter, J.P. Beilby, Y. Ben-Shlomo, R. Benediktsson, A.J. Bennett, S. Bergmann, M. Bochud, E. Boerwinkle, A. Bonnefond, L.L. Bonnycastle, K. Borch-Johnsen, Y. Bottcher, E. Brunner, S.J. Bumpstead, G. Charpentier, Y.D. Chen, P. Chines, R. Clarke, L.J. Coin, M.N. Cooper, M. Cornelis, G. Crawford, L. Crisponi, I.N. Day, E.J. De Geus, J. Delplanque, C. Dina, M.R. Erdos, A.C. Fedson, A. Fischer-Rosinsky, N.G. Forouhi, C.S. Fox, R. Frants, M.G. Franzosi, P. Galan, M.O. Goodarzi, J. Graessler, C.J. Groves, S. Grundy, R. Gwilliam, U. Gyllensten, S. Hadjadj, et al. 2010. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nature Genetics 42: 105–116.PubMedCrossRefGoogle Scholar
  12. Feng, Y., G. Mao, X. Ren, H. Xing, G. Tang, Q. Li, X. Li, L. Sun, J. Yang, W. Ma, X. Wang, and X. Xu. 2008. Ser1369Ala variant in sulfonylurea receptor gene ABCC8 is associated with antidiabetic efficacy of gliclazide in Chinese type 2 diabetic patients. Diabetes Care 31: 1939–1944.PubMedCrossRefGoogle Scholar
  13. Fischer, J., L. Koch, C. Emmerling, J. Vierkotten, T. Peters, J.C. Bruning, and U. Ruther. 2009. Inactivation of the Fto gene protects from obesity. Nature 458: 894–898.PubMedCrossRefGoogle Scholar
  14. Fisher, R.A. 1918. The correlation between relatives on the supposition of Mendelian inheritance. Philosophical Transactions of the Royal Society of Edinburg 52: 399–433.CrossRefGoogle Scholar
  15. Frayling, T.M., N.J. Timpson, M.N. Weedon, E. Zeggini, R.M. Freathy, C.M. Lindgren, J.R. Perry, K.S. Elliott, H. Lango, N.W. Rayner, B. Shields, L.W. Harries, J.C. Barrett, S. Ellard, C.J. Groves, B. Knight, A.M. Patch, A.R. Ness, S. Ebrahim, D.A. Lawlor, S.M. Ring, Y. Ben-Shlomo, M.R. Jarvelin, U. Sovio, A.J. Bennett, D. Melzer, L. Ferrucci, R.J. Loos, I. Barroso, N.J. Wareham, F. Karpe, K.R. Owen, L.R. Cardon, M. Walker, G.A. Hitman, C.N. Palmer, A.S. Doney, A.D. Morris, G.D. Smith, A.T. Hattersley, and M.I. Mccarthy. 2007. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 316: 889–894.PubMedCrossRefGoogle Scholar
  16. Gloyn, A.L., M.N. Weedon, K.R. Owen, M.J. Turner, B.A. Knight, G. Hitman, M. Walker, J.C. Levy, M. Sampson, S. Halford, M.I. Mccarthy, A.T. Hattersley, and T.M. Frayling. 2003. Large-scale association studies of variants in genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23 K variant is associated with type 2 diabetes. Diabetes 52: 568–572.PubMedCrossRefGoogle Scholar
  17. Grant, S.F., G. Thorleifsson, I. Reynisdottir, R. Benediktsson, A. Manolescu, J. Sainz, A. Helgason, H. Stefansson, V. Emilsson, A. Helgadottir, U. Styrkarsdottir, K.P. Magnusson, G.B. Walters, E. Palsdottir, T. Jonsdottir, T. Gudmundsdottir, A. Gylfason, J. Saemundsdottir, R.L. Wilensky, M.P. Reilly, D.J. Rader, Y. Bagger, C. Christiansen, V. Gudnason, G. Sigurdsson, U. Thorsteinsdottir, J.R. Gulcher, A. Kong, and K. Stefansson. 2006. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nature Genetics 38: 320–323.PubMedCrossRefGoogle Scholar
  18. Grarup, N., G. Andersen, N.T. Krarup, A. Albrechtsen, O. Schmitz, T. Jorgensen, K. Borch-Johnsen, T. Hansen, and O. Pedersen. 2008. Association testing of novel type 2 diabetes risk alleles in the JAZF1, CDC123/CAMK1D, TSPAN8, THADA, ADAMTS9, and NOTCH2 loci with insulin release, insulin sensitivity, and obesity in a population-based sample of 4,516 glucose-tolerant middle-aged Danes. Diabetes 57: 2534–2540.PubMedCrossRefGoogle Scholar
  19. Grarup, N., C.S. Rose, E.A. Andersson, G. Andersen, A.L. Nielsen, A. Albrechtsen, J.O. Clausen, S.S. Rasmussen, T. Jorgensen, A. Sandbaek, T. Lauritzen, O. Schmitz, T. Hansen, and O. Pedersen. 2007. Studies of association of variants near the HHEX, CDKN2A/B, and IGF2BP2 genes with type 2 diabetes and impaired insulin release in 10,705 Danish subjects: validation and extension of genome-wide association studies. Diabetes 56: 3105–3111.PubMedCrossRefGoogle Scholar
  20. Groenewoud, M.J., J.M. Dekker, A. Fritsche, E. Reiling, G. Nijpels, R.J. Heine, J.A. Maassen, F. Machicao, S.A. Schafer, H.U. Haring, L.M. T Hart, and T.W. Van Haeften. 2008. Variants of CDKAL1 and IGF2BP2 affect first-phase insulin secretion during hyperglycaemic clamps. Diabetologia 51: 1659–1663.PubMedCrossRefGoogle Scholar
  21. Hardeland, R. 2005. Antioxidative protection by melatonin: multiplicity of mechanisms from radical detoxification to radical avoidance. Endocrine 27: 119–130.PubMedCrossRefGoogle Scholar
  22. Harries, L.W., S. Ellard, A. Stride, N.G. Morgan, and A.T. Hattersley. 2006. Isomers of the TCF1 gene encoding hepatocyte nuclear factor-1 alpha show differential expression in the pancreas and define the relationship between mutation position and clinical phenotype in monogenic diabetes. Human Molecular Genetics 15: 2216–2224.PubMedCrossRefGoogle Scholar
  23. Haumaitre, C., E. Barbacci, M. Jenny, M.O. Ott, G. Gradwohl, and S. Cereghini. 2005. Lack of TCF2/vHNF1 in mice leads to pancreas agenesis. Proceedings of the National Academy of Sciences of the United States of America 102: 1490–1495.PubMedCrossRefGoogle Scholar
  24. Heid, I.M., A.U. Jackson, J.C. Randall, T.W. Winkler, L. Qi, V. Steinthorsdottir, G. Thorleifsson, M.C. Zillikens, E.K. Speliotes, R. Magi, T. Workalemahu, C.C. White, N. Bouatia-Naji, T.B. Harris, S.I. Berndt, E. Ingelsson, C.J. Willer, M.N. Weedon, J. Luan, S. Vedantam, T. Esko, T.O. Kilpelainen, Z. Kutalik, S. Li, K.L. Monda, A.L. Dixon, C.C. Holmes, L.M. Kaplan, L. Liang, J.L. Min, M.F. Moffatt, C. Molony, G. Nicholson, E.E. Schadt, K.T. Zondervan, M.F. Feitosa, T. Ferreira, H. Lango Allen, R.J. Weyant, E. Wheeler, A.R. Wood, K. Estrada, M.E. Goddard, G. Lettre, M. Mangino, D.R. Nyholt, S. Purcell, A.V. Smith, P.M. Visscher, J. Yang, S.A. Mccarroll, J. Nemesh, B.F. Voight, D. Absher, N. Amin, T. Aspelund, L. Coin, N.L. Glazer, C. Hayward, N.L. Heard-Costa, J.J. Hottenga, A. Johansson, T. Johnson, M. Kaakinen, K. Kapur, S. Ketkar, J.W. Knowles, P. Kraft, A.T. Kraja, C. Lamina, M.F. Leitzmann, B. Mcknight, A.P. Morris, K.K. Ong, J.R. Perry, M.J. Peters, O. Polasek, I. Prokopenko, N.W. Rayner, S. Ripatti, F. Rivadeneira, N.R. Robertson, S. Sanna, U. Sovio, I. Surakka, A. Teumer, S. Van Wingerden, V. Vitart, J.H. Zhao, C. Cavalcanti-Proenca, P.S. Chines, E. Fisher, J.R. Kulzer, C. Lecoeur, N. Narisu, C. Sandholt, L.J. Scott, K. Silander, K. Stark, M.L. Tammesoo, et al. 2010. Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution. Nature Genetics 42: 949–960.PubMedCrossRefGoogle Scholar
  25. Hemminki, K., X. Li, K. Sundquist, and J. Sundquist. 2010. Familial risks for type 2 diabetes in Sweden. Diabetes Care 33: 293–297.PubMedCrossRefGoogle Scholar
  26. International Diabetes Federation. 2011. IDF Diabetes Atlas, 5th ed. Brussels, Belgium: International Diabetes Federation.Google Scholar
  27. Imamura, M., S. Maeda, T. Yamauchi, K. Hara, K. Yasuda, T. Morizono, A. Takahashi, M. Horikoshi, M. Nakamura, H. Fujita, T. Tsunoda, M. Kubo, H. Watada, H. Maegawa, M. Okada-Iwabu, M. Iwabu, N. Shojima, T. Ohshige, S. Omori, M. Iwata, H. Hirose, K. Kaku, C. Ito, Y. Tanaka, K. Tobe, A. Kashiwagi, R. Kawamori, M. Kasuga, N. Kamatani, Y. Nakamura, and T. Kadowaki. 2012. A single-nucleotide polymorphism in ANK1 is associated with susceptibility to type 2 diabetes in Japanese populations. Human Molecular Genetics 21: 3042–3049.PubMedCrossRefGoogle Scholar
  28. Ingelsson, E., C. Langenberg, M.F. Hivert, I. Prokopenko, V. Lyssenko, J. Dupuis, R. Magi, S. Sharp, A.U. Jackson, T.L. Assimes, P. Shrader, J.W. Knowles, B. Zethelius, F.A. Abbasi, R.N. Bergman, A. Bergmann, C. Berne, M. Boehnke, L.L. Bonnycastle, S.R. Bornstein, T.A. Buchanan, S.J. Bumpstead, Y. Bottcher, P. Chines, F.S. Collins, C.C. Cooper, E.M. Dennison, M.R. Erdos, E. Ferrannini, C.S. Fox, J. Graessler, K. Hao, B. Isomaa, K.A. Jameson, P. Kovacs, J. Kuusisto, M. Laakso, C. Ladenvall, K.L. Mohlke, M.A. Morken, N. Narisu, D.M. Nathan, L. Pascoe, F. Payne, J.R. Petrie, A.A. Sayer, P.E. Schwarz, L.J. Scott, H.M. Stringham, M. Stumvoll, A.J. Swift, A.C. Syvanen, T. Tuomi, J. Tuomilehto, A. Tonjes, T.T. Valle, G.H. Williams, L. Lind, I. Barroso, T. Quertermous, M. Walker, N.J. Wareham, J.B. Meigs, M.I. Mccarthy, L. Groop, R.M. Watanabe, and J.C. Florez. 2010. Detailed physiologic characterization reveals diverse mechanisms for novel genetic Loci regulating glucose and insulin metabolism in humans. Diabetes 59: 1266–1275.PubMedCrossRefGoogle Scholar
  29. Kilpelainen, T.O., M.C. Zillikens, A. Stancakova, F.M. Finucane, J.S. Ried, C. Langenberg, W. Zhang, J.S. Beckmann, J. Luan, L. Vandenput, U. Styrkarsdottir, Y. Zhou, A.V. Smith, J.H. Zhao, N. Amin, S. Vedantam, S.Y. Shin, T. Haritunians, M. Fu, M.F. Feitosa, M. Kumari, B.V. Halldorsson, E. Tikkanen, M. Mangino, C. Hayward, C. Song, A.M. Arnold, Y.S. Aulchenko, B.A. Oostra, H. Campbell, L.A. Cupples, K.E. Davis, A. Doring, G. Eiriksdottir, K. Estrada, J.M. Fernandez-Real, M. Garcia, C. Gieger, N.L. Glazer, C. Guiducci, A. Hofman, S.E. Humphries, B. Isomaa, L.C. Jacobs, A. Jula, D. Karasik, M.K. Karlsson, K.T. Khaw, L.J. Kim, M. Kivimaki, N. Klopp, B. Kuhnel, J. Kuusisto, Y. Liu, O. Ljunggren, M. Lorentzon, R.N. Luben, B. Mcknight, D. Mellstrom, B.D. Mitchell, V. Mooser, J.M. Moreno, S. Mannisto, J.R. O’connell, L. Pascoe, L. Peltonen, B. Peral, M. Perola, B.M. Psaty, V. Salomaa, D.B. Savage, R.K. Semple, T. Skaric-Juric, G. Sigurdsson, K.S. Song, T.D. Spector, A.C. Syvanen, P.J. Talmud, G. Thorleifsson, U. Thorsteinsdottir, A.G. Uitterlinden, C.M. Van Duijn, A. Vidal-Puig, S.H. Wild, A.F. Wright, D.J. Clegg, E. Schadt, J.F. Wilson, I. Rudan, S. Ripatti, I.B. Borecki, A.R. Shuldiner, E. Ingelsson, J.O. Jansson, R.C. Kaplan, V. Gudnason, T.B. Harris, L. Groop, D.P. Kiel, F. Rivadeneira, et al. 2011. Genetic variation near IRS1 associates with reduced adiposity and an impaired metabolic profile. Nature Genetics 43: 753–760.PubMedCrossRefGoogle Scholar
  30. Kirchheiner, J., J. Brockmoller, I. Meineke, S. Bauer, W. Rohde, C. Meisel, and I. Roots. 2002. Impact of CYP2C9 amino acid polymorphisms on glyburide kinetics and on the insulin and glucose response in healthy volunteers. Clinical Pharmacology and Therapeutics 71: 286–296.PubMedCrossRefGoogle Scholar
  31. Kirchhoff, K., F. Machicao, A. Haupt, S.A. Schafer, O. Tschritter, H. Staiger, N. Stefan, H.U. Haring, and A. Fritsche. 2008. Polymorphisms in the TCF7L2, CDKAL1 and SLC30A8 genes are associated with impaired proinsulin conversion. Diabetologia 51: 597–601.PubMedCrossRefGoogle Scholar
  32. Kong, A., V. Steinthorsdottir, G. Masson, G. Thorleifsson, P. Sulem, S. Besenbacher, A. Jonasdottir, A. Sigurdsson, K.T. Kristinsson, M.L. Frigge, A. Gylfason, P.I. Olason, S.A. Gudjonsson, S. Sverrisson, S.N. Stacey, B. Sigurgeirsson, K.R. Benediktsdottir, H. Sigurdsson, T. Jonsson, R. Benediktsson, J.H. Olafsson, O.T. Johannsson, A.B. Hreidarsson, G. Sigurdsson, A.C. Ferguson-Smith, D.F. Gudbjartsson, U. Thorsteinsdottir, and K. Stefansson. 2009. Parental origin of sequence variants associated with complex diseases. Nature 462: 868–874.PubMedCrossRefGoogle Scholar
  33. Kooner, J.S., D. Saleheen, X. Sim, J. Sehmi, W. Zhang, P. Frossard, L.F. Been, K.S. Chia, A.S. Dimas, N. Hassanali, T. Jafar, J.B. Jowett, X. Li, V. Radha, S.D. Rees, F. Takeuchi, R. Young, T. Aung, A. Basit, M. Chidambaram, D. Das, E. Grundberg, A.K. Hedman, Z.I. Hydrie, M. Islam, C.C. Khor, S. Kowlessur, M.M. Kristensen, S. Liju, W.Y. Lim, D.R. Matthews, J. Liu, A.P. Morris, A.C. Nica, J.M. Pinidiyapathirage, I. Prokopenko, A. Rasheed, M. Samuel, N. Shah, A.S. Shera, K.S. Small, C. Suo, A.R. Wickremasinghe, T.Y. Wong, M. Yang, F. Zhang, G.R. Abecasis, A.H. Barnett, M. Caulfield, P. Deloukas, T.M. Frayling, P. Froguel, N. Kato, P. Katulanda, M.A. Kelly, J. Liang, V. Mohan, D.K. Sanghera, J. Scott, M. Seielstad, P.Z. Zimmet, P. Elliott, Y.Y. Teo, M.I. Mccarthy, J. Danesh, E.S. Tai, and J.C. Chambers. 2011. Genome-wide association study in individuals of South Asian ancestry identifies six new type 2 diabetes susceptibility loci. Nature Genetics 43: 984–989.PubMedCrossRefGoogle Scholar
  34. Korkmaz, A., S. Ma, T. Topal, S. Rosales-Corral, D.X. Tan, and R.J. Reiter. 2012. Glucose: a vital toxin and potential utility of melatonin in protecting against the diabetic state. Molecular and Cellular Endocrinology 349: 128–137.PubMedCrossRefGoogle Scholar
  35. Kwak, S.H., S.H. Kim, Y.M. Cho, M.J. Go, Y.S. Cho, S.H. Choi, M.K. Moon, H.S. Jung, H.D. Shin, H.M. Kang, N.H. Cho, I.K. Lee, S.Y. Kim, B.G. Han, H.C. Jang, and K.S. Park. 2012. A genome-wide association study of gestational diabetes mellitus in Korean women. Diabetes 61: 531–541.PubMedCrossRefGoogle Scholar
  36. Li, H., T.O. Kilpelainen, C. Liu, J. Zhu, Y. Liu, C. Hu, Z. Yang, W. Zhang, W. Bao, S. Cha, Y. Wu, T. Yang, A. Sekine, B.Y. Choi, C.S. Yajnik, D. Zhou, F. Takeuchi, K. Yamamoto, J.C. Chan, K.R. Mani, L.F. Been, M. Imamura, E. Nakashima, N. Lee, T. Fujisawa, S. Karasawa, W. Wen, C.V. Joglekar, W. Lu, Y. Chang, Y. Xiang, Y. Gao, S. Liu, Y. Song, S.H. Kwak, H.D. Shin, K.S. Park, C.H. Fall, J.Y. Kim, P.C. Sham, K.S. Lam, W. Zheng, X. Shu, H. Deng, H. Ikegami, G.V. Krishnaveni, D.K. Sanghera, L. Chuang, L. Liu, R. Hu, Y. Kim, M. Daimon, K. Hotta, W. Jia, J.S. Kooner, J.C. Chambers, G.R. Chandak, R.C. Ma, S. Maeda, R. Dorajoo, M. Yokota, R. Takayanagi, N. Kato, X. Lin, and R.J. Loos. 2012. Association of genetic variation in FTO with risk of obesity and type 2 diabetes with data from 96,551 East and South Asians. Diabetologia 55: 981–995.PubMedCrossRefGoogle Scholar
  37. Loos, R.J., C.M. Lindgren, S. Li, E. Wheeler, J.H. Zhao, I. Prokopenko, M. Inouye, R.M. Freathy, A.P. Attwood, J.S. Beckmann, S.I. Berndt, K.B. Jacobs, S.J. Chanock, R.B. Hayes, S. Bergmann, A.J. Bennett, S.A. Bingham, M. Bochud, M. Brown, S. Cauchi, J.M. Connell, C. Cooper, G.D. Smith, I. Day, C. Dina, S. De, E.T. Dermitzakis, A.S. Doney, K.S. Elliott, P. Elliott, D.M. Evans, I. Sadaf Farooqi, P. Froguel, J. Ghori, C.J. Groves, R. Gwilliam, D. Hadley, A.S. Hall, A.T. Hattersley, J. Hebebrand, I.M. Heid, C. Lamina, C. Gieger, T. Illig, T. Meitinger, H.E. Wichmann, B. Herrera, A. Hinney, S.E. Hunt, M.R. Jarvelin, T. Johnson, J.D. Jolley, F. Karpe, A. Keniry, K.T. Khaw, R.N. Luben, M. Mangino, J. Marchini, W.L. Mcardle, R. Mcginnis, D. Meyre, P.B. Munroe, A.D. Morris, A.R. Ness, M.J. Neville, A.C. Nica, K.K. Ong, S. O’rahilly, K.R. Owen, C.N. Palmer, K. Papadakis, S. Potter, A. Pouta, L. Qi, J.C. Randall, N.W. Rayner, S.M. Ring, M.S. Sandhu, A. Scherag, M.A. Sims, K. Song, N. Soranzo, E.K. Speliotes, H.E. Syddall, S.A. Teichmann, N.J. Timpson, J.H. Tobias, M. Uda, C.I. Vogel, C. Wallace, D.M. Waterworth, M.N. Weedon, C.J. Wraight Willer, X. Yuan, E. Zeggini, J.N. Hirschhorn, D.P. Strachan, W.H. Ouwehand, M.J. Caulfield, et al. 2008. Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nature Genetics 40: 768–775.PubMedCrossRefGoogle Scholar
  38. Lyssenko, V., A. Jonsson, P. Almgren, N. Pulizzi, B. Isomaa, T. Tuomi, G. Berglund, D. Altshuler, P. Nilsson, and L. Groop. 2008. Clinical risk factors, DNA variants, and the development of type 2 diabetes. The New England journal of medicine 359: 2220–2232.PubMedCrossRefGoogle Scholar
  39. Lyssenko, V., C.L. Nagorny, M.R. Erdos, N. Wierup, A. Jonsson, P. Spegel, M. Bugliani, R. Saxena, M. Fex, N. Pulizzi, B. Isomaa, T. Tuomi, P. Nilsson, J. Kuusisto, J. Tuomilehto, M. Boehnke, D. Altshuler, F. Sundler, J.G. Eriksson, A.U. Jackson, M. Laakso, P. Marchetti, R.M. Watanabe, H. Mulder, and L. Groop. 2009. Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion. Nature Genetics 41: 82–88.PubMedCrossRefGoogle Scholar
  40. Manolio, T.A., F.S. Collins, N.J. Cox, D.B. Goldstein, L.A. Hindorff, D.J. Hunter, M.I. Mccarthy, E.M. Ramos, L.R. Cardon, A. Chakravarti, J.H. Cho, A.E. Guttmacher, A. Kong, L. Kruglyak, E. Mardis, C.N. Rotimi, M. Slatkin, D. Valle, A.S. Whittemore, M. Boehnke, A.G. Clark, E.E. Eichler, G. Gibson, J.L. Haines, T.F. Mackay, S.A. Mccarroll, and P.M. Visscher. 2009. Finding the missing heritability of complex diseases. Nature 461: 747–753.PubMedCrossRefGoogle Scholar
  41. Meigs, J.B., L.A. Cupples, and P.W. Wilson. 2000. Parental transmission of type 2 diabetes: the Framingham Offspring Study. Diabetes 49: 2201–2207.PubMedCrossRefGoogle Scholar
  42. Meigs, J.B., P. Shrader, L.M. Sullivan, J.B. Mcateer, C.S. Fox, J. Dupuis, A.K. Manning, J.C. Florez, P.W. Wilson, R.B. D’agostino Sr, and L.A. Cupples. 2008. Genotype score in addition to common risk factors for prediction of type 2 diabetes. The New England journal of medicine 359: 2208–2219.PubMedCrossRefGoogle Scholar
  43. Morris, A.P., B.F. Voight, T.M. Teslovich, T. Ferreira, A.V. Segre, V. Steinthorsdottir, R.J. Strawbridge, H. Khan, H. Grallert, A. Mahajan, I. Prokopenko, H.M. Kang, C. Dina, T. Esko, R.M. Fraser, S. Kanoni, A. Kumar, V. Lagou, C. Langenberg, J. Luan, C.M. Lindgren, M. Muller-Nurasyid, S. Pechlivanis, N.W. Rayner, L.J. Scott, S. Wiltshire, L. Yengo, L. Kinnunen, E.J. Rossin, S. Raychaudhuri, A.D. Johnson, A.S. Dimas, R.J. Loos, S. Vedantam, H. Chen, J.C. Florez, C. Fox, C.T. Liu, D. Rybin, D.J. Couper, W.H. Kao, M. Li, M.C. Cornelis, P. Kraft, Q. Sun, R.M. Van Dam, H.M. Stringham, P.S. Chines, K. Fischer, P. Fontanillas, O.L. Holmen, S.E. Hunt, A.U. Jackson, A. Kong, R. Lawrence, J. Meyer, J.R. Perry, C.G. Platou, S. Potter, E. Rehnberg, N. Robertson, S. Sivapalaratnam, A. Stancakova, K. Stirrups, G. Thorleifsson, E. Tikkanen, A.R. Wood, P. Almgren, M. Atalay, R. Benediktsson, L.L. Bonnycastle, N. Burtt, J. Carey, G. Charpentier, A.T. Crenshaw, A.S. Doney, M. Dorkhan, S. Edkins, V. Emilsson, E. Eury, T. Forsen, K. Gertow, B. Gigante, G.B. Grant, C.J. Groves, C. Guiducci, C. Herder, A.B. Hreidarsson, J. Hui, A. James, A. Jonsson, W. Rathmann, N. Klopp, J. Kravic, K. Krjutskov, C. Langford, K. Leander, E. Lindholm, S. Lobbens, S. Mannisto, et al. 2012. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nature Genetics 44: 981–990.PubMedCrossRefGoogle Scholar
  44. Nielsen, E.M., L. Hansen, B. Carstensen, S.M. Echwald, T. Drivsholm, C. Glumer, B. Thorsteinsson, K. Borch-Johnsen, T. Hansen, and O. Pedersen. 2003. The E23 K variant of Kir6.2 associates with impaired post-OGTT serum insulin response and increased risk of type 2 diabetes. Diabetes 52: 573–577.PubMedCrossRefGoogle Scholar
  45. Palmer, N.D., C.W. Mcdonough, P.J. Hicks, B.H. Roh, M.R. Wing, S.S. An, J.M. Hester, J.N. Cooke, M.A. Bostrom, M.E. Rudock, M.E. Talbert, J.P. Lewis, A. Ferrara, L. Lu, J.T. Ziegler, M.M. Sale, J. Divers, D. Shriner, A. Adeyemo, C.N. Rotimi, M.C. Ng, C.D. Langefeld, B.I. Freedman, D.W. Bowden, B.F. Voight, L.J. Scott, V. Steinthorsdottir, A.P. Morris, C. Dina, R.P. Welch, E. Zeggini, C. Huth, Y.S. Aulchenko, G. Thorleifsson, L.J. Mcculloch, T. Ferreira, H. Grallert, N. Amin, G. Wu, C.J. Willer, S. Raychaudhuri, S.A. Mccarroll, C. Langenberg, O.M. Hofmann, J. Dupuis, L. Qi, A.V. Segre, M. Van Hoek, P. Navarro, K. Ardlie, B. Balkau, R. Benediktsson, A.J. Bennett, R. Blagieva, E. Boerwinkle, L.L. Bonnycastle, K.B. Bostrom, B. Bravenboer, S. Bumpstead, N.P. Burtt, G. Charpentier, P.S. Chines, M. Cornelis, D.J. Couper, G. Crawford, A.S. Doney, K.S. Elliott, A.L. Elliott, M.R. Erdos, C.S. Fox, C.S. Franklin, M. Ganser, C. Gieger, N. Grarup, T. Green, S. Griffin, C.J. Groves, C. Guiducci, S. Hadjadj, N. Hassanali, C. Herder, B. Isomaa, A.U. Jackson, P.R. Johnson, T. Jorgensen, W.H. Kao, N. Klopp, A. Kong, P. Kraft, J. Kuusisto, T. Lauritzen, M. Li, A. Lieverse, C.M. Lindgren, V. Lyssenko, M. Marre, T. Meitinger, K. Midthjell, M.A. Morken, N. Narisu, et al. 2012. A genome-wide association search for type 2 diabetes genes in African Americans. PLoS ONE 7: e29202.PubMedCrossRefGoogle Scholar
  46. Park, K.S. 2011. The search for genetic risk factors of type 2 diabetes mellitus. Diabetes Metab J 35: 12–22.PubMedCrossRefGoogle Scholar
  47. Pascoe, L., A. Tura, S.K. Patel, I.M. Ibrahim, E. Ferrannini, E. Zeggini, M.N. Weedon, A. Mari, A.T. Hattersley, M.I. Mccarthy, T.M. Frayling, and M. Walker. 2007. Common variants of the novel type 2 diabetes genes CDKAL1 and HHEX/IDE are associated with decreased pancreatic beta-cell function. Diabetes 56: 3101–3104.PubMedCrossRefGoogle Scholar
  48. Pearson, T.A., and T.A. Manolio. 2008. How to interpret a genome-wide association study. Journal of the American Medical Association 299: 1335–1344.PubMedCrossRefGoogle Scholar
  49. Qi, L., M.C. Cornelis, P. Kraft, K.J. Stanya, W.H. Linda Kao, J.S. Pankow, J. Dupuis, J.C. Florez, C.S. Fox, G. Pare, Q. Sun, C.J. Girman, C.C. Laurie, D.B. Mirel, T.A. Manolio, D.I. Chasman, E. Boerwinkle, P.M. Ridker, D.J. Hunter, J.B. Meigs, C.H. Lee, F.B. Hu, and R.M. Van Dam. 2010. Genetic variants at 2q24 are associated with susceptibility to type 2 diabetes. Human Molecular Genetics 19: 2706–2715.PubMedCrossRefGoogle Scholar
  50. Reynisdottir, I., G. Thorleifsson, R. Benediktsson, G. Sigurdsson, V. Emilsson, A.S. Einarsdottir, E.E. Hjorleifsdottir, G.T. Orlygsdottir, G.T. Bjornsdottir, J. Saemundsdottir, S. Halldorsson, S. Hrafnkelsdottir, S.B. Sigurjonsdottir, S. Steinsdottir, M. Martin, J.P. Kochan, B.K. Rhees, S.F. Grant, M.L. Frigge, A. Kong, V. Gudnason, K. Stefansson, and J.R. Gulcher. 2003. Localization of a susceptibility gene for type 2 diabetes to chromosome 5q34-q35.2. American Journal of Human Genetics 73: 323–335.PubMedCrossRefGoogle Scholar
  51. Saxena, R., B.F. Voight, V. Lyssenko, N.P. Burtt, P.I. De Bakker, H. Chen, J.J. Roix, S. Kathiresan, J.N. Hirschhorn, M.J. Daly, T.E. Hughes, L. Groop, D. Altshuler, P. Almgren, J.C. Florez, J. Meyer, K. Ardlie, K. Bengtsson Bostrom, B. Isomaa, G. Lettre, U. Lindblad, H.N. Lyon, O. Melander, C. Newton-Cheh, P. Nilsson, M. Orho-Melander, L. Rastam, E.K. Speliotes, M.R. Taskinen, T. Tuomi, C. Guiducci, A. Berglund, J. Carlson, L. Gianniny, R. Hackett, L. Hall, J. Holmkvist, E. Laurila, M. Sjogren, M. Sterner, A. Surti, M. Svensson, R. Tewhey, B. Blumenstiel, M. Parkin, M. Defelice, R. Barry, W. Brodeur, J. Camarata, N. Chia, M. Fava, J. Gibbons, B. Handsaker, C. Healy, K. Nguyen, C. Gates, C. Sougnez, D. Gage, M. Nizzari, S.B. Gabriel, G.W. Chirn, Q. Ma, H. Parikh, D. Richardson, D. Ricke, and S. Purcell. 2007. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316: 1331–1336.PubMedCrossRefGoogle Scholar
  52. Schork, N.J., S.S. Murray, K.A. Frazer, and E.J. Topol. 2009. Common vs. rare allele hypotheses for complex diseases. Current Opinion in Genetics and Development 19: 212–219.PubMedCrossRefGoogle Scholar
  53. Scott, L.J., K.L. Mohlke, L.L. Bonnycastle, C.J. Willer, Y. Li, W.L. Duren, M.R. Erdos, H.M. Stringham, P.S. Chines, A.U. Jackson, L. Prokunina-Olsson, C.J. Ding, A.J. Swift, N. Narisu, T. Hu, R. Pruim, R. Xiao, X.Y. Li, K.N. Conneely, N.L. Riebow, A.G. Sprau, M. Tong, P.P. White, K.N. Hetrick, M.W. Barnhart, C.W. Bark, J.L. Goldstein, L. Watkins, F. Xiang, J. Saramies, T.A. Buchanan, R.M. Watanabe, T.T. Valle, L. Kinnunen, G.R. Abecasis, E.W. Pugh, K.F. Doheny, R.N. Bergman, J. Tuomilehto, F.S. Collins, and M. Boehnke. 2007. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 316: 1341–1345.PubMedCrossRefGoogle Scholar
  54. Scott, R.A., V. Lagou, R.P. Welch, E. Wheeler, M.E. Montasser, J. Luan, R. Magi, R.J. Strawbridge, E. Rehnberg, S. Gustafsson, S. Kanoni, L.J. Rasmussen-Torvik, L. Yengo, C. Lecoeur, D. Shungin, S. Sanna, C. Sidore, P.C. Johnson, J.W. Jukema, T. Johnson, A. Mahajan, N. Verweij, G. Thorleifsson, J.J. Hottenga, S. Shah, A.V. Smith, B. Sennblad, C. Gieger, P. Salo, M. Perola, N.J. Timpson, D.M. Evans, B.S. Pourcain, Y. Wu, J.S. Andrews, J. Hui, L.F. Bielak, W. Zhao, M. Horikoshi, P. Navarro, A. Isaacs, J.R. O’connell, K. Stirrups, V. Vitart, C. Hayward, T. Esko, E. Mihailov, R.M. Fraser, T. Fall, B.F. Voight, S. Raychaudhuri, H. Chen, C.M. Lindgren, A.P. Morris, N.W. Rayner, N. Robertson, D. Rybin, C.T. Liu, J.S. Beckmann, S.M. Willems, P.S. Chines, A.U. Jackson, H.M. Kang, H.M. Stringham, K. Song, T. Tanaka, J.F. Peden, A. Goel, A.A. Hicks, P. An, M. Muller-Nurasyid, A. Franco-Cereceda, L. Folkersen, L. Marullo, H. Jansen, A.J. Oldehinkel, M. Bruinenberg, J.S. Pankow, K.E. North, N.G. Forouhi, R.J. Loos, S. Edkins, T.V. Varga, G. Hallmans, H. Oksa, M. Antonella, R. Nagaraja, S. Trompet, I. Ford, S.J. Bakker, A. Kong, M. Kumari, B. Gigante, C. Herder, P.B. Munroe, M. Caulfield, J. Antti, M. Mangino, K. Small, I. Miljkovic, et al. 2012. Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways. Nature Genetics 44: 991–1005.PubMedCrossRefGoogle Scholar
  55. Sesti, G., E. Laratta, M. Cardellini, F. Andreozzi, S. Del Guerra, C. Irace, A. Gnasso, M. Grupillo, R. Lauro, M.L. Hribal, F. Perticone, and P. Marchetti. 2006. The E23 K variant of KCNJ11 encoding the pancreatic beta-cell adenosine 5′-triphosphate-sensitive potassium channel subunit Kir6.2 is associated with an increased risk of secondary failure to sulfonylurea in patients with type 2 diabetes. Journal of Clinical Endocrinology and Metabolism 91: 2334–2339.PubMedCrossRefGoogle Scholar
  56. Shea, J., V. Agarwala, A.A. Philippakis, J. Maguire, E. Banks, M. Depristo, B. Thomson, C. Guiducci, R.C. Onofrio, S. Kathiresan, S. Gabriel, N.P. Burtt, M.J. Daly, L. Groop, and D. Altshuler. 2011. Comparing strategies to fine-map the association of common SNPs at chromosome 9p21 with type 2 diabetes and myocardial infarction. Nature Genetics 43: 801–805.PubMedCrossRefGoogle Scholar
  57. Shu, Y., S.A. Sheardown, C. Brown, R.P. Owen, S. Zhang, R.A. Castro, A.G. Ianculescu, L. Yue, J.C. Lo, E.G. Burchard, C.M. Brett, and K.M. Giacomini. 2007. Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action. The Journal of Clinical Investigation 117: 1422–1431.PubMedCrossRefGoogle Scholar
  58. Simonis-Bik, A.M., G. Nijpels, T.W. Van Haeften, J.J. Houwing-Duistermaat, D.I. Boomsma, E. Reiling, E.C. Van Hove, M. Diamant, M.H. Kramer, R.J. Heine, J.A. Maassen, P.E. Slagboom, G. Willemsen, J.M. Dekker, E.M. Eekhoff, E.J. De Geus, and L.M. THart. 2010. Gene variants in the novel type 2 diabetes loci CDC123/CAMK1D, THADA, ADAMTS9, BCL11A, and MTNR1B affect different aspects of pancreatic beta-cell function. Diabetes 59: 293–301.PubMedCrossRefGoogle Scholar
  59. Sladek, R., G. Rocheleau, J. Rung, C. Dina, L. Shen, D. Serre, P. Boutin, D. Vincent, A. Belisle, S. Hadjadj, B. Balkau, B. Heude, G. Charpentier, T.J. Hudson, A. Montpetit, A.V. Pshezhetsky, M. Prentki, B.I. Posner, D.J. Balding, D. Meyre, C. Polychronakos, and P. Froguel. 2007. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 445: 881–885.PubMedCrossRefGoogle Scholar
  60. Small, K.S., A.K. Hedman, E. Grundberg, A.C. Nica, G. Thorleifsson, A. Kong, U. Thorsteindottir, S.Y. Shin, H.B. Richards, N. Soranzo, K.R. Ahmadi, C.M. Lindgren, K. Stefansson, E.T. Dermitzakis, P. Deloukas, T.D. Spector, and M.I. Mccarthy. 2011. Identification of an imprinted master trans regulator at the KLF14 locus related to multiple metabolic phenotypes. Nature Genetics 43: 561–564.PubMedCrossRefGoogle Scholar
  61. Smushkin, G., M. Sathananthan, A. Sathananthan, C. Dalla Man, F. Micheletto, A.R. Zinsmeister, C. Cobelli, and A. Vella. 2012. Diabetes-associated common genetic variation and its association with GLP-1 concentrations and response to exogenous GLP-1. Diabetes 61: 1082–1089.PubMedCrossRefGoogle Scholar
  62. Sparso, T., G. Andersen, A. Albrechtsen, T. Jorgensen, K. Borch-Johnsen, A. Sandbaek, T. Lauritzen, J. Wasson, M.A. Permutt, B. Glaser, S. Madsbad, O. Pedersen, and T. Hansen. 2008. Impact of polymorphisms in WFS1 on prediabetic phenotypes in a population-based sample of middle-aged people with normal and abnormal glucose regulation. Diabetologia 51: 1646–1652.PubMedCrossRefGoogle Scholar
  63. Tan, J.T., S. Nurbaya, D. Gardner, S. Ye, E.S. Tai, and D.P. Ng. 2009. Genetic variation in KCNQ1 associates with fasting glucose and beta-cell function: a study of 3,734 subjects comprising three ethnicities living in Singapore. Diabetes 58: 1445–1449.PubMedCrossRefGoogle Scholar
  64. Tanihara, Y., S. Masuda, T. Sato, T. Katsura, O. Ogawa, and K. Inui. 2007. Substrate specificity of MATE1 and MATE2-K, human multidrug and toxin extrusions/H(+)-organic cation antiporters. Biochemical Pharmacology 74: 359–371.PubMedCrossRefGoogle Scholar
  65. Tsai, F.J., C.F. Yang, C.C. Chen, L.M. Chuang, C.H. Lu, C.T. Chang, T.Y. Wang, R.H. Chen, C.F. Shiu, Y.M. Liu, C.C. Chang, P. Chen, C.H. Chen, C.S. Fann, Y.T. Chen, and J.Y. Wu. 2010. A genome-wide association study identifies susceptibility variants for type 2 diabetes in Han Chinese. PLoS Genetics 6: e1000847.PubMedCrossRefGoogle Scholar
  66. Vassy, J.L., and J.B. Meigs. 2012. Is genetic testing useful to predict type 2 diabetes? Best Practice and Research Clinical Endocrinology and Metabolism 26: 189–201.PubMedCrossRefGoogle Scholar
  67. Villareal, D.T., H. Robertson, G.I. Bell, B.W. Patterson, H. Tran, B. Wice, and K.S. Polonsky. 2010. TCF7L2 variant rs7903146 affects the risk of type 2 diabetes by modulating incretin action. Diabetes 59: 479–485.PubMedCrossRefGoogle Scholar
  68. Voight, B.F., H.M. Kang, J. Ding, C.D. Palmer, C. Sidore, P.S. Chines, N.P. Burtt, C. Fuchsberger, Y. Li, J. Erdmann, T.M. Frayling, I.M. Heid, A.U. Jackson, T. Johnson, T.O. Kilpelainen, C.M. Lindgren, A.P. Morris, I. Prokopenko, J.C. Randall, R. Saxena, N. Soranzo, E.K. Speliotes, T.M. Teslovich, E. Wheeler, J. Maguire, M. Parkin, S. Potter, N.W. Rayner, N. Robertson, K. Stirrups, W. Winckler, S. Sanna, A. Mulas, R. Nagaraja, F. Cucca, I. Barroso, P. Deloukas, R.J. Loos, S. Kathiresan, P.B. Munroe, C. Newton-Cheh, A. Pfeufer, N.J. Samani, H. Schunkert, J.N. Hirschhorn, D. Altshuler, M.I. Mccarthy, G.R. Abecasis, and M. Boehnke. 2012. The metabochip, a custom genotyping array for genetic studies of metabolic, cardiovascular, and anthropometric traits. PLoS Genetics 8: e1002793.PubMedCrossRefGoogle Scholar
  69. Voight, B.F., L.J. Scott, V. Steinthorsdottir, A.P. Morris, C. Dina, R.P. Welch, E. Zeggini, C. Huth, Y.S. Aulchenko, G. Thorleifsson, L.J. Mcculloch, T. Ferreira, H. Grallert, N. Amin, G. Wu, C.J. Willer, S. Raychaudhuri, S.A. Mccarroll, C. Langenberg, O.M. Hofmann, J. Dupuis, L. Qi, A.V. Segre, M. Van Hoek, P. Navarro, K. Ardlie, B. Balkau, R. Benediktsson, A.J. Bennett, R. Blagieva, E. Boerwinkle, L.L. Bonnycastle, K. Bengtsson Bostrom, B. Bravenboer, S. Bumpstead, N.P. Burtt, G. Charpentier, P.S. Chines, M. Cornelis, D.J. Couper, G. Crawford, A.S. Doney, K.S. Elliott, A.L. Elliott, M.R. Erdos, C.S. Fox, C.S. Franklin, M. Ganser, C. Gieger, N. Grarup, T. Green, S. Griffin, C.J. Groves, C. Guiducci, S. Hadjadj, N. Hassanali, C. Herder, B. Isomaa, A.U. Jackson, P.R. Johnson, T. Jorgensen, W.H. Kao, N. Klopp, A. Kong, P. Kraft, J. Kuusisto, T. Lauritzen, M. Li, A. Lieverse, C.M. Lindgren, V. Lyssenko, M. Marre, T. Meitinger, K. Midthjell, M.A. Morken, N. Narisu, P. Nilsson, K.R. Owen, F. Payne, J.R. Perry, A.K. Petersen, C. Platou, C. Proenca, I. Prokopenko, W. Rathmann, N.W. Rayner, N.R. Robertson, G. Rocheleau, M. Roden, M.J. Sampson, R. Saxena, B.M. Shields, P. Shrader, G. Sigurdsson, T. Sparso, K. Strassburger, H.M. Stringham, Q. Sun, A.J. Swift, B. Thorand, et al. 2010. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nature Genetics 42: 579–589.PubMedCrossRefGoogle Scholar
  70. Wang, D.S., J.W. Jonker, Y. Kato, H. Kusuhara, A.H. Schinkel, and Y. Sugiyama. 2002. Involvement of organic cation transporter 1 in hepatic and intestinal distribution of metformin. The Journal of pharmacology and experimental therapeutics 302: 510–515.PubMedCrossRefGoogle Scholar
  71. Wang, H., P. Maechler, P.A. Antinozzi, K.A. Hagenfeldt, and C.B. Wollheim. 2000. Hepatocyte nuclear factor 4alpha regulates the expression of pancreatic beta -cell genes implicated in glucose metabolism and nutrient-induced insulin secretion. Journal of Biological Chemistry 275: 35953–35959.PubMedCrossRefGoogle Scholar
  72. Wei, F.Y., T. Suzuki, S. Watanabe, S. Kimura, T. Kaitsuka, A. Fujimura, H. Matsui, M. Atta, H. Michiue, M. Fontecave, K. Yamagata, and K. Tomizawa. 2011. Deficit of tRNA(Lys) modification by Cdkal1 causes the development of type 2 diabetes in mice. J Clin Invest 121: 3598–3608.PubMedCrossRefGoogle Scholar
  73. World Health Organization. 1999. Definition, diagnosis and classification of diabetes mellitus and its complications. Geneva: World Health Organization.Google Scholar
  74. WTCCC. 2007. Genome-wide association study of 14, 000 cases of seven common diseases and 3, 000 shared controls. Nature 447: 661–678.CrossRefGoogle Scholar
  75. Yamauchi, T., K. Hara, S. Maeda, K. Yasuda, A. Takahashi, M. Horikoshi, M. Nakamura, H. Fujita, N. Grarup, S. Cauchi, D.P. Ng, R.C. Ma, T. Tsunoda, M. Kubo, H. Watada, H. Maegawa, M. Okada-Iwabu, M. Iwabu, N. Shojima, H.D. Shin, G. Andersen, D.R. Witte, T. Jorgensen, T. Lauritzen, A. Sandbaek, T. Hansen, T. Ohshige, S. Omori, I. Saito, K. Kaku, H. Hirose, W.Y. So, D. Beury, J.C. Chan, K.S. Park, E.S. Tai, C. Ito, Y. Tanaka, A. Kashiwagi, R. Kawamori, M. Kasuga, P. Froguel, O. Pedersen, N. Kamatani, Y. Nakamura, and T. Kadowaki. 2010. A genome-wide association study in the Japanese population identifies susceptibility loci for type 2 diabetes at UBE2E2 and C2CD4A-C2CD4B. Nature Genetics 42: 864–868.PubMedCrossRefGoogle Scholar
  76. Yang, Y., B.H. Chang, V. Yechoor, W. Chen, L. Li, M.J. Tsai, and L. Chan. 2011. The Kruppel-like zinc finger protein GLIS3 transactivates neurogenin 3 for proper fetal pancreatic islet differentiation in mice. Diabetologia 54: 2595–2605.PubMedCrossRefGoogle Scholar
  77. Zeggini, E., L.J. Scott, R. Saxena, B.F. Voight, J.L. Marchini, T. Hu, P.I. De Bakker, G.R. Abecasis, P. Almgren, G. Andersen, K. Ardlie, K.B. Bostrom, R.N. Bergman, L.L. Bonnycastle, K. Borch-Johnsen, N.P. Burtt, H. Chen, P.S. Chines, M.J. Daly, P. Deodhar, C.J. Ding, A.S. Doney, W.L. Duren, K.S. Elliott, M.R. Erdos, T.M. Frayling, R.M. Freathy, L. Gianniny, H. Grallert, N. Grarup, C.J. Groves, C. Guiducci, T. Hansen, C. Herder, G.A. Hitman, T.E. Hughes, B. Isomaa, A.U. Jackson, T. Jorgensen, A. Kong, K. Kubalanza, F.G. Kuruvilla, J. Kuusisto, C. Langenberg, H. Lango, T. Lauritzen, Y. Li, C.M. Lindgren, V. Lyssenko, A.F. Marvelle, C. Meisinger, K. Midthjell, K.L. Mohlke, M.A. Morken, A.D. Morris, N. Narisu, P. Nilsson, K.R. Owen, C.N. Palmer, F. Payne, J.R. Perry, E. Pettersen, C. Platou, I. Prokopenko, L. Qi, L. Qin, N.W. Rayner, M. Rees, J.J. Roix, A. Sandbaek, B. Shields, M. Sjogren, V. Steinthorsdottir, H.M. Stringham, A.J. Swift, G. Thorleifsson, U. Thorsteinsdottir, N.J. Timpson, T. Tuomi, J. Tuomilehto, M. Walker, R.M. Watanabe, M.N. Weedon, C.J. Willer, T. Illig, K. Hveem, F.B. Hu, M. Laakso, K. Stefansson, O. Pedersen, N.J. Wareham, I. Barroso, A.T. Hattersley, F.S. Collins, L. Groop, M.I. Mccarthy, M. Boehnke, and D. Altshuler. 2008. Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nature Genetics 40: 638–645.PubMedCrossRefGoogle Scholar
  78. Zeggini, E., M.N. Weedon, C.M. Lindgren, T.M. Frayling, K.S. Elliott, H. Lango, N.J. Timpson, J.R. Perry, N.W. Rayner, R.M. Freathy, J.C. Barrett, B. Shields, A.P. Morris, S. Ellard, C.J. Groves, L.W. Harries, J.L. Marchini, K.R. Owen, B. Knight, L.R. Cardon, M. Walker, G.A. Hitman, A.D. Morris, A.S. Doney, M.I. Mccarthy, and A.T. Hattersley. 2007. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 316: 1336–1341.PubMedCrossRefGoogle Scholar
  79. Zhou, K., C. Bellenguez, C.C. Spencer, A.J. Bennett, R.L. Coleman, R. Tavendale, S.A. Hawley, L.A. Donnelly, C. Schofield, C.J. Groves, L. Burch, F. Carr, A. Strange, C. Freeman, J.M. Blackwell, E. Bramon, M.A. Brown, J.P. Casas, A. Corvin, N. Craddock, P. Deloukas, S. Dronov, A. Duncanson, S. Edkins, E. Gray, S. Hunt, J. Jankowski, C. Langford, H.S. Markus, C.G. Mathew, R. Plomin, A. Rautanen, S.J. Sawcer, N.J. Samani, R. Trembath, A.C. Viswanathan, N.W. Wood, L.W. Harries, A.T. Hattersley, A.S. Doney, H. Colhoun, A.D. Morris, C. Sutherland, D.G. Hardie, L. Peltonen, M.I. Mccarthy, R.R. Holman, C.N. Palmer, P. Donnelly, and E.R. Pearson. 2011. Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes. Nature Genetics 43: 117–120.PubMedCrossRefGoogle Scholar
  80. Zhou, K., L. Donnelly, L. Burch, R. Tavendale, A.S. Doney, G. Leese, A.T. Hattersley, M.I. Mccarthy, A.D. Morris, C.C. Lang, C.N. Palmer, and E.R. Pearson. 2010. Loss-of-function CYP2C9 variants improve therapeutic response to sulfonylureas in type 2 diabetes: a Go-DARTS study. Clinical Pharmacology and Therapeutics 87: 52–56.PubMedCrossRefGoogle Scholar

Copyright information

© The Pharmaceutical Society of Korea 2013

Authors and Affiliations

  1. 1.Department of Internal MedicineSeoul National University HospitalSeoulSouth Korea
  2. 2.Department of Internal MedicineSeoul National University College of MedicineSeoulSouth Korea
  3. 3.WCU Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology and College of MedicineSeoul National UniversitySeoulSouth Korea

Personalised recommendations